Stockreport

Recruitment and Enrollment Underway at Eight Sites for Innovation Pharma’s Phase 2 Clinical Trial of Brilacidin for COVID-19

INNOVATION PHARMACEUTICAL  (IPIX) 
US:NASDAQ Investor Relations: ipharminc.com/press-release
PDF WAKEFIELD, Mass., March 05, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today reports [Read more]